STOCKSCREENR

0J8Z.L

LSE

Illumina, Inc.

$126.00+4.00(+3.28%)Mkt Cap: $19.14B

Key Stats

Market Cap

$19.14B

P/E Ratio

27.66

EPS

$4.55

Dividend Yield

0.00%

52-Week Range

$89.21 — $232.20

Volume

297

Avg Volume

8.48K

Beta

1.49

Price Alerts for 0J8Z.L

Get alerted when 0J8Z.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

27.66

Forward P/E

24.64

PEG Ratio

0.13

P/S (TTM)

4.60

P/B (TTM)

7.33

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

0.35%

ROA (TTM)

0.13%

ROIC

—

Gross Margin

0.66%

Operating Margin

0.20%

Net Margin

—

Debt/Equity

0.94

Current Ratio

2.08

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.80%

EPS Growth (5Y)

-0.80%

Sales Growth (3Y)

-0.02%

Sales Growth (5Y)

+0.07%

EPS Est (This Year)

$5.11

EPS Est (Next Year)

$5.82

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$10.67

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

200

Outstanding Shares

152.80M

Float

148.51M

Free Float %

97.19%

Technicals

RSI (14)

59.37

SMA 20

$122.70

SMA 50

$134.08

SMA 200

$112.51

ATR (14)

4.60

Volatility (Week)

0.02%

Volatility (Month)

0.04%

Pattern

—

Performance

1 Day

-1.59%

1 Week

-6.26%

1 Month

-8.41%

3 Months

-4.66%

6 Months

+28.03%

1 Year

—

YTD

-6.76%

All-Time High

$154.91

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

LSE

IPO Date

2018-01-29

Employees

8970

CEO

Jacob Thaysen

Index Membership

—

Website

https://www.illumina.com

Illumina, Inc. (0J8Z.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $19.14B, a P/E ratio of 27.66, 0J8Z.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0J8Z.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0R2M.L

Regeneron Pharmaceuticals, Inc.

$685.53

+1.37%

$74.06B

0M3Q.L

Zoetis Inc.

$115.60

+1.72%

$55.54B

0J2O.L

Halozyme Therapeutics, Inc.

$64.11

+1.60%

$7.57B

0HD2.L

Alnylam Pharmaceuticals, Inc.

$319.08

+7.54%

$42.32B

0RD1.L

Camurus AB (publ)

$530.55

+0.06%

$31.64B

0JAV.L

Insmed Incorporated

$136.55

+1.81%

$29.44B

Frequently Asked Questions

What is Illumina, Inc.'s P/E ratio?

Illumina, Inc. (0J8Z.L) has a trailing twelve-month (TTM) P/E ratio of 27.66. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Illumina, Inc. pay a dividend?

No, Illumina, Inc. (0J8Z.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Illumina, Inc.'s market cap?

Illumina, Inc. (0J8Z.L) has a market capitalization of $19.14 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has 0J8Z.L performed this year?

Illumina, Inc. (0J8Z.L) has returned -6.76% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.